AAAAAA

   
Results: 1-14 |
Results: 14
Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and invivo
Authors: Buske, C Feuring-Buske, M Antonchuk, J Rosten, P Hogge, DE Eaves, CJ Humphries, RK
Citation: C. Buske et al., Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and invivo, BLOOD, 97(8), 2001, pp. 2286-2292
Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia
Authors: Feuring-Buske, M Hogge, DE
Citation: M. Feuring-buske et De. Hogge, Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia, BLOOD, 97(12), 2001, pp. 3882-3889
Treatment of steroid-resistant acute graft-versus-host disease with rabbitantithymocyte globulin
Authors: McCaul, KG Nevill, TJ Barnett, MJ Toze, CL Currie, CJ Sutherland, HJ Conneally, EA Shepherd, JD Nantel, SH Hogge, DE Klingemann, HG
Citation: Kg. Mccaul et al., Treatment of steroid-resistant acute graft-versus-host disease with rabbitantithymocyte globulin, J HEMATH ST, 9(3), 2000, pp. 367-374
Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma
Authors: Lohrisch, CA Nevill, TJ Barnett, MJ Hogge, DE Connors, JM Keown, PA Gascoyne, RD
Citation: Ca. Lohrisch et al., Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma, LEUK LYMPH, 39(1-2), 2000, pp. 195
Allografting for indolent lymphoid neoplasms
Authors: Toze, CL Shepherd, JD Connors, JM Voss, NJ Gascoyne, RD Hogge, DE Klingemann, HG Nantel, SH Nevill, TJ Phillips, GL Reece, DE Sutherland, HJ Conneally, EA Barnett, MJ
Citation: Cl. Toze et al., Allografting for indolent lymphoid neoplasms, ANN ONCOL, 11, 2000, pp. 59-61
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias
Authors: Frankel, AE McCubrey, JA Miller, MS Delatte, S Ramage, J Kiser, M Kucera, GL Alexander, RL Beran, M Tagge, EP Kreitman, RJ Hogge, DE
Citation: Ae. Frankel et al., Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias, LEUKEMIA, 14(4), 2000, pp. 576-585
Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML)
Authors: Guan, Y Hogge, DE
Citation: Y. Guan et De. Hogge, Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML), LEUKEMIA, 14(12), 2000, pp. 2135-2141
Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant
Authors: Hogge, DE Lambie, K Sutherland, HJ Benny, WB Dalal, B Currie, C Barnett, MJ Eaves, AC Eaves, CJ
Citation: De. Hogge et al., Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant, BONE MAR TR, 25(6), 2000, pp. 589-598
Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia
Authors: Toze, CL Shepherd, JD Connors, JM Voss, NJ Gascoyne, RD Hogge, DE Klingemann, HG Nantel, SH Nevill, TJ Phillips, GL Reece, DE Sutherland, HJ Barnett, MJ
Citation: Cl. Toze et al., Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia, BONE MAR TR, 25(6), 2000, pp. 605-612
Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells
Authors: Kawagoe, H Humphries, RK Blair, A Sutherland, HJ Hogge, DE
Citation: H. Kawagoe et al., Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells, LEUKEMIA, 13(5), 1999, pp. 687-698
Retroviral marking of acute myelogenous leukemia progenitors that initiatelong-term culture and growth in immunodeficient mice
Authors: Ailles, LE Humphries, RK Thomas, TE Hogge, DE
Citation: Le. Ailles et al., Retroviral marking of acute myelogenous leukemia progenitors that initiatelong-term culture and growth in immunodeficient mice, EXP HEMATOL, 27(11), 1999, pp. 1609-1620
Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice
Authors: Ailles, LE Gerhard, B Kawagoe, M Hogge, DE
Citation: Le. Ailles et al., Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice, BLOOD, 94(5), 1999, pp. 1761-1772
Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience
Authors: Micallef, INM Chhanabhai, M Gascoyne, RD Shepherd, JD Fung, HC Nantel, SH Toze, CL Klingemann, HG Sutherland, HJ Hogge, DE Nevill, TJ Le, A Barnett, MJ
Citation: Inm. Micallef et al., Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience, BONE MAR TR, 22(10), 1998, pp. 981-987
Bone marrow transplantation for adults with acute leukaemia and 11q23 chromosomal abnormalities
Authors: Forrest, DL Nevill, TJ Horsman, DE Brockington, DA Fung, HC Toze, CL Conneally, EA Hogge, DE Sutherland, HJ Nantel, SH Shepherd, JD Barnett, MJ
Citation: Dl. Forrest et al., Bone marrow transplantation for adults with acute leukaemia and 11q23 chromosomal abnormalities, BR J HAEM, 103(3), 1998, pp. 630-638
Risultati: 1-14 |